Janet Yoon

Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)

Ami V. Desai, Giles Robinson, Karen Gauvain et al. · Neuro-Oncology · 2022 · 138 citations · Full text

Medicine, Oncology, Pharmacology +17

Can a pain management and palliative care curriculum improve the opioid prescribing practices of medical residents?

Wayne A. Ury, Maike Rahn, Victorio R. Tolentino et al. · Journal of General Internal Medicine · 2002 · 62 citations · Full text

Medicine, Medical Education, Pain Management +15

Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.

Giles Robinson, Amar Gajjar, Karen Gauvain et al. · Journal of Clinical Oncology · 2019 · 61 citations

Medicine, Neurology, Oncology +17

Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

J. Sybil Biermann, Angela C. Hirbe, Shivani Ahlawat et al. · Journal of the National Comprehensive Cancer Network · 2025 · 40 citations

Medicine, Oncology, Radiation Oncology +17

Treatment of infantile choriocarcinoma of the liver

Janet Yoon, R. Cartland Burns, Marcio H. Malogolowkin et al. · Pediatric Blood & Cancer · 2005 · 26 citations

Medicine, Oncology, Pediatrics +17